Health and Healthcare
577 Articles
ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps…
According to Reuters, Wilbur Ross say the bailout package does not address the core of problem which is mortgage payments.…
There is some very hopeful data out there this morning on cancer survival. Bristol-Myers Squibb Co. (NYSE: BMY) and Medarex,…
Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its…
ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The…
According to Reuters, large Yahoo! (YHOO) holder Capital Research want to know whether vote counts from the company’s annula meeting…
Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY)…
According to Reuters, GM (GM) is expected to post a huge loss. Reuters reports that oil company profits rose, but…
Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a…
ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating…
If you thought this was a bad day for the market with the DJIA trading well under that 12,000 psychological…
These are ten of the analyst calls we are focusing on this Wednesday morning in pre-market trading: Bristol-Myers (NYSE: BMY)…
Bristol-Myers Squibb (NYSE: BMY) has submitted an open shelf offering today for an undetermined amount. The offering includes a combination…
Bristol-Myers Squibb Company (NYSE: BMY) came out with earnings at $0.35 EPS and reaffirmed 2008 guidance of $1.36 to $1.46…
Medarex, Inc. (NASDAQ: MEDX) wants to clarify a few issues regarding the study halt from Pfizer (NYSE: PFE) this week…
Our top personal finance-related articles today. Your wallet will thank you later.